Home - Products - Others - Other Targets - [Lys8,Asn9] Neurotensin LANT-6 (8-13)

[Lys8,Asn9] Neurotensin LANT-6 (8-13)

CAS No. ———

[Lys8,Asn9] Neurotensin LANT-6 (8-13)( ——— )

Catalog No. M41750 CAS No. ———

[Lys8,Asn9] Neurotensin LANT-6 (8-13)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    [Lys8,Asn9] Neurotensin LANT-6 (8-13)
  • Note
    Research use only, not for human use.
  • Brief Description
    [Lys8,Asn9] Neurotensin LANT-6 (8-13)
  • Description
    [Lys8,Asn9] Neurotensin LANT-6 (8-13)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    746.91
  • Molecular Formula
    C36H58N8O9
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • KL-11743

    KL-11743 specifically blocks glucose metabolism, triggering an acute collapse in NADH pools and a striking accumulation of aspartate, indicating a dramatic shift toward oxidative phosphorylation in the mitochondria.

  • Quin C1

    Quin C1 is a selective and potent formylpeptide receptor 2 (FPR2/ALX) agonist with anti-inflammatory activity, inhibits neutrophil and lymphocyte production in BALF, and reduces the expression of TNF-α, IL-1β, KC, and TGF-β1.Quin C1 is used in the study of lung injury.

  • c(Bua-Cpa-Thi-Val-As...

    c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm a highly efficient, selective and short-acting peptide V2 receptor agonist (V2R), with EC50s of hV2R and rV2R being 0.25 and 0.05 nM, respectively.